Toine van der Heijden

14PUBLICATIONS
84CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Exercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 26, 2026
Trial design drives outcomes: harmonising efficacy across BCG-unresponsive bladder carcinoma in situ trials.

|Aug 21, 2026
Fruit and vegetable consumption, dietary and plasma carotenoids and risks of recurrence and progression in patients with non-muscle-invasive bladder cancer.

|Jul 28, 2026
Correction: Pérez et al. Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer. Biomedicines 2025, 13, 740.

|Apr 01, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Roberto Contieri, Paolo Gontero, Rodolfo Hurle

|Jun 30, 2025
Physical activity and risks of recurrence and progression among patients with non-muscle invasive bladder cancer.

Ivy Beeren, Joann Kiebach, Jasper P Hof

|Jun 09, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO Study.

Chantal F Stockem, Alberto Gil-Jimenez, Hamza Ali

Pageof 3

Frequent Collaborators

4 joint publications

Lambertus A L M Kiemeney

4 joint publications

Alina Vrieling

4 joint publications

Katja K H Aben

3 joint publications

Niven Mehra